相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical Respiratory Samples
Kuiama Lewandowski et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2
Xingguang Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Lirong Zou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China
Zhiliang Hu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Yixuan J. Hou et al.
CELL (2020)
Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
Leticia Moreno-Fierros et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2
Jianzhong Shi et al.
SCIENCE (2020)
Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
Su-Jin Park et al.
MBIO (2020)
Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia
Leon Caly et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Intranasal and epicutaneous administration of Toll- like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice
Eunice E. To et al.
SCIENTIFIC REPORTS (2019)
Recent clinical trends in Toll-like receptor targeting therapeutics
Muhammad Ayaz Anwar et al.
MEDICINAL RESEARCH REVIEWS (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Temporal cytokine and lymphoid responses to an inhaled TLR7 antedrug agonist in the cynomolgus monkey demonstrates potential safety and tolerability of this approach
John Bell et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Advances in Antiviral Therapies Targeting Toll-like Receptors
Masaud Shah et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease
Tracy A. Delaney et al.
JOURNAL OF IMMUNOLOGY (2016)
Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity
Brendon Y. Chua et al.
MBIO (2015)
Mapping influenza transmission in the ferret model to transmission in humans
Michael G. Buhnerkempe et al.
ELIFE (2015)
Generation of adaptive immune responses following influenza virus challenge is not compromised by pre-treatment with the TLR-2 agonist Pam2Cys
Edin Jessica Mifsud et al.
FRONTIERS IN IMMUNOLOGY (2015)
Novel drugs targeting Toll-like receptors for antiviral therapy
Mira C. Patel et al.
FUTURE VIROLOGY (2014)
TLR-dependent human mucosal epithelial cell responses to microbial pathogens
Ryan McClure et al.
FRONTIERS IN IMMUNOLOGY (2014)
Intranasal Administration of the TLR2 Agonist Pam2Cys Provides Rapid Protection against Influenza in Mice
Amabel C. L. Tan et al.
MOLECULAR PHARMACEUTICS (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development
Alyson Ann Kelvin et al.
Journal of Infection in Developing Countries (2012)
The role of TLR2 in infect on and immunity
Laura Oliveira-Nascimento et al.
FRONTIERS IN IMMUNOLOGY (2012)
Targeting of Toll-like receptors: a decade of progress in combating infectious diseases
Mona Hedayat et al.
LANCET INFECTIOUS DISEASES (2011)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The Synthetic Bacterial Lipopeptide Pam3CSK4 Modulates Respiratory Syncytial Virus Infection Independent of TLR Activation
D. Tien Nguyen et al.
PLOS PATHOGENS (2010)
Pathology of experimental SARS coronavirus infection in cats and ferrets
J. M. A. Van den Brand et al.
VETERINARY PATHOLOGY (2008)
TLR1- and TLR6-independent recognition of bacterial lipopeptides
U Buwitt-Beckmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
NS Zhong et al.
LANCET (2003)